Case number 2017-1694
Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | MOMENTA PHARMACEUTICALS, INC. v. BRISTOL-MYERS SQUIBB COMPANY [OPINION - PRECEDENTIAL] [precedential] (0) |
| Mar 18, 2019 | 108 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [593570] [JAB] [Entered: 03/18/2019 01:30 PM] (0) |
| Feb 7, 2019 | 106 | OPINION filed for the court by Newman, Circuit Judge; Dyk, Circuit Judge and Chen, Circuit Judge. Granting motion to modify protective order [101] filed by Appellant Momenta Pharmaceuticals, Inc.; granting motion to correct/supplement [90] filed by Appellee Bristol-Myers Squibb Company; Precedential Opinion. [583986] [PBC] [Entered: 02/07/2019 10:03 AM] (0) |
| Feb 7, 2019 | 107 | JUDGMENT filed. DISMISSED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [583990] [PBC] [Entered: 02/07/2019 10:11 AM] (0) |
| Dec 10, 2018 | 105 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellee Bristol-Myers Squibb Company. Service: 12/10/2018 by email. [570619] [17-1694] [Christopher Sipes] [Entered: 12/10/2018 04:34 PM] (0) |
| Nov 13, 2018 | 104 | RESPONSE of Appellee Bristol-Myers Squibb Company to the court order to show cause [100] , court order [100]. Service: 11/13/2018 by email. [564614] [17-1694] [Christopher Sipes] [Entered: 11/13/2018 05:10 PM] (0) |
| Nov 2, 2018 | 101 | MOTION of Appellant Momenta Pharmaceuticals, Inc. to modify the protective order [Consent: unopposed]. Service: 11/02/2018 by email. [562276] [17-1694] [Deanne Maynard] [Entered: 11/02/2018 02:04 PM] (0) |
| Nov 2, 2018 | 102 | RESPONSE of Appellant Momenta Pharmaceuticals, Inc. to the court order to show cause [100] , court order [100]. Service: 11/02/2018 by email. [562385] [17-1694] [Deanne Maynard] [Entered: 11/02/2018 05:00 PM] (0) |
| Nov 2, 2018 | 103 | Sealed or confidential document received [Momenta's Confidential Response to Order to Show Cause] (corresponding to Doc No. [102]) for Appellant Momenta Pharmaceuticals, Inc.. Service: 11/02/2018 by email. [562386] [17-1694] [Deanne Maynard] [Entered: 11/02/2018 05:02 PM] (0) |
| Oct 23, 2018 | 100 | ORDER filed. Momenta Pharmaceuticals, Inc. is ordered to show cause why the appeal should not be dismissed as moot. Any response shall be filed no later than ten days after the date of issuance of this order. Any response by Bristol-Myers Squibb Co. shall be filed no later than ten days after filing by Momenta of any response to this order. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [559551] [JAB] [Entered: 10/23/2018 01:29 PM] (0) |
| Oct 3, 2018 | 99 | RESPONSE of Appellee Bristol-Myers Squibb Company to the supplemental authority [98] filed by Appellant Momenta Pharmaceuticals, Inc.. Service: 10/03/2018 by email. [554406] [17-1694] [Christopher Sipes] [Entered: 10/03/2018 10:14 AM] (0) |
| Oct 1, 2018 | 98 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Momenta Pharmaceuticals, Inc.. Service: 10/01/2018 by email. [553876] [17-1694] [Deanne Maynard] [Entered: 10/01/2018 04:52 PM] (5) |
| Aug 13, 2018 | 97 | RESPONSE of Appellant Momenta Pharmaceuticals, Inc. to the supplemental authority [96] filed by Appellee Bristol-Myers Squibb Company. Service: 08/13/2018 by email. [542433] [17-1694] [Deanne Maynard] [Entered: 08/13/2018 02:24 PM] (4) |
| Aug 9, 2018 | 96 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellee Bristol-Myers Squibb Company. Service: 08/08/2018 by email. [541894] [17-1694] [Christopher Sipes] [Entered: 08/09/2018 05:31 PM] (4) |
| Jun 14, 2018 | 95 | CORRECTED ENTRY: RESPONSE of Appellee Bristol-Myers Squibb Company to the supplemental authority [94] filed by Appellant Momenta Pharmaceuticals, Inc. in 17-1694. Service: 06/14/2018 by email. [529602]--[Edited 06/15/2018 by SMJ - Reason: to correct event] [Christopher Sipes] [Entered: 06/14/2018 05:35 PM] (4) |
| Jun 4, 2018 | 94 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Momenta Pharmaceuticals, Inc.. Service: 06/04/2018 by email. [526667] [17-1694] [Deanne Maynard] [Entered: 06/04/2018 02:35 PM] (4) |
| Dec 5, 2017 | 93 | Submitted after ORAL ARGUMENT by Ms. Deanne Maynard for Momenta Pharmaceuticals, Inc. and Mr. Christopher Neil Sipes, Esq. for Bristol-Myers Squibb Company. Panel: Judge: Newman , Judge: Dyk , Judge: Chen. [480252] [JCP] [Entered: 12/05/2017 10:54 AM] (0) |
| Nov 22, 2017 | 92 | REPLY of Appellee Bristol-Myers Squibb Company to response filed by Appellant in 17-1694 , Doc. No [91]. Service: 11/22/2017 by email. [478023] [Christopher Sipes] [Entered: 11/22/2017 04:24 PM] (7) |
| Nov 21, 2017 | 91 | RESPONSE of Appellant Momenta Pharmaceuticals, Inc. to the motion to correct/supplement other [90] filed by Appellee Bristol-Myers Squibb Company in 17-1694. Service: 11/21/2017 by email. [477496] [Deanne Maynard] [Entered: 11/21/2017 02:48 PM] (7) |
| Nov 17, 2017 | 90 | MOTION of Appellee Bristol-Myers Squibb Company to correct or supplement [Supplement Record on Standing]. Any response is due within 10 days of service [Consent: opposed]. Service: 11/17/2017 by email. [476663] [Christopher Sipes] [Entered: 11/17/2017 03:03 PM] (13) |
| Nov 13, 2017 | 89 | Response to oral argument order from the Appellant Momenta Pharmaceuticals, Inc.. designating Deanne E. Maynard as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [474713] [Deanne Maynard] [Entered: 11/13/2017 11:20 AM] (0) |
| Nov 8, 2017 | 88 | Response to oral argument order from the Appellee Bristol-Myers Squibb Company. designating Christopher N. Sipes as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [474103] [Christopher Sipes] [Entered: 11/08/2017 03:15 PM] (0) |
| Oct 20, 2017 | 87 | NOTICE OF CALENDARING. Panel: 1712G. Case scheduled Dec 05, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 11/15/2017. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [469394] [JAB] [Entered: 10/20/2017 12:17 PM] (0) |
| Sep 29, 2017 | 85 | OVERDUE NOTICE to counsel for Amici Curiae Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America: The record of this case indicates that the Certificate of Interest has not been filed. A completed certificate of Interest must be submitted in accordance with Fed. Cir. R. 47.4 by 10/02/2017. Service as of this date by Clerk of Court. [464387] [CAB] [Entered: 09/29/2017 02:13 PM] (0) |
| Sep 29, 2017 | 86 | Certificate of Interest for the Amici Curiae Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America. Service: 09/29/2017 by email. [464447] [Brian Boynton] [Entered: 09/29/2017 03:21 PM] (1) |
| Sep 27, 2017 | 84 | 6 paper copies of the Confidential Joint Appendix (Vols. I-II) [79] received from Appellant Momenta Pharmaceuticals, Inc. [463886] [CW] [Entered: 09/27/2017 04:15 PM] (0) |
| Sep 25, 2017 | 83 | 6 paper copies of the Reply Brief [73] received from Appellant Momenta Pharmaceuticals, Inc. [463336] [CW] [Entered: 09/25/2017 03:48 PM] (0) |
| Sep 22, 2017 | 81 | NOTICE OF DEFICIENCY: The party document Document No. [78] filed by Appellant Momenta Pharmaceuticals, Inc. in 17-1694 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [CLERK'S NOTE: The correct event is "Certificate of Compliance Modification of Protective Order (R11/17)" which is under the "Forms and Certificates" event category.] [462933] [CAB] [Entered: 09/22/2017 10:35 AM] (0) |
| Sep 22, 2017 | 82 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellant Momenta Pharmaceuticals, Inc.. Service: 09/22/2017 by email. [463032] [Deanne Maynard] [Entered: 09/22/2017 03:05 PM] (5) |
| Sep 21, 2017 | 75 | Notice from Appellee Bristol-Myers Squibb Company regarding conflicts with oral argument (Conflict as principal counsel in two appeals possibly scheduled for same day on December 2017 calendar.). Service: 09/21/2017 by email. [462877] [Christopher Sipes] [Entered: 09/21/2017 05:01 PM] (2) |
| Sep 21, 2017 | 76 | TENDERED from Appellant Momenta Pharmaceuticals, Inc. and Appellee Bristol-Myers Squibb Company. Title: CONFIDENTIAL JOINT APPENDIX Service: 09/21/2017 by email. [462896] [Deanne Maynard] [Entered: 09/21/2017 07:47 PM] (0) |
| Sep 21, 2017 | 77 | TENDERED from Appellant Momenta Pharmaceuticals, Inc. and Appellee Bristol-Myers Squibb Company. Title: JOINT APPENDIX. Service: 09/21/2017 by email. [462897] [Deanne Maynard] [Entered: 09/21/2017 07:51 PM] (1053) |
| Sep 21, 2017 | 78 | Certificate of Compliance with Fed. Cir. R. 30(h)(1)(B) for Appellant Momenta Pharmaceuticals, Inc.. Service: 09/21/2017 by email. [462898] [Deanne Maynard] [Entered: 09/21/2017 08:05 PM] (0) |
| Sep 21, 2017 | 79 | CONFIDENTIAL JOINT APPENDIX, VOLS. I - II FILED for Momenta Pharmaceuticals, Inc. [76]. Number of Pages: 1,060. Service: 09/21/2017 by email. The paper copies of the brief should be received by the court on or before 09/29/2017. [462928] --[Edited 09/22/2017 by clerk to add deadline for paper copies.] [CAB] [Entered: 09/22/2017 10:22 AM] (0) |
| Sep 21, 2017 | 80 | JOINT APPENDIX, VOLS. I - II FILED for Momenta Pharmaceuticals, Inc. [77]. Number of Pages: 1053. Service: 09/21/2017 by email. [462929] [CAB] [Entered: 09/22/2017 10:28 AM] (1053) |
| Sep 20, 2017 | 74 | ORDER filed. The motion [72] is denied in part. The case will be placed on the December 2017 oral argument calendar. Service: 09/20/2017 by clerk. [462247] [LMS] [Entered: 09/20/2017 08:36 AM] (2) |
| Sep 19, 2017 | 71 | TENDERED from Appellant Momenta Pharmaceuticals, Inc.. Title: REPLY BRIEF. Service: 09/19/2017 by email. [462100] [Deanne Maynard] [Entered: 09/19/2017 01:56 PM] (42) |
| Sep 19, 2017 | 72 | MOTION of Appellant Momenta Pharmaceuticals, Inc. to expedite hearing. Any response is due within 10 days of service [Consent: opposed]. Service: 09/19/2017 by email. [462109] [Deanne Maynard] [Entered: 09/19/2017 02:14 PM] (12) |
| Sep 19, 2017 | 73 | REPLY BRIEF FILED for Appellant Momenta Pharmaceuticals, Inc. [71]. Number of Pages: 31. Service: 09/19/2017 by email. The paper copies of the brief should be received by the court on or before 09/26/2017. [462127] [CAB] [Entered: 09/19/2017 02:37 PM] (42) |
| Sep 15, 2017 | 70 | 6 paper copies of the Amicus Brief [66] received from Amici Curiae Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America. [461306] [CW] [Entered: 09/15/2017 12:46 PM] (0) |
| Sep 14, 2017 | 69 | 6 paper copies of the Corrected Confidential Opening Response Brief [67] received from Appellee Bristol-Myers Squibb Company. [461027] [CW] [Entered: 09/14/2017 02:56 PM] (0) |
| Sep 12, 2017 | 59 | Entry of appearance for Brian M. Boynton as principal counsel for Pharmaceutical Research and Manufacturers of America, Biotechnology Innovation Organization. Service: 09/12/2017 by email. [460403] [Brian Boynton] [Entered: 09/12/2017 01:57 PM] (1) |
| Sep 12, 2017 | 60 | Entry of appearance for Thomas G. Saunders as of counsel for Pharmaceutical Research and Manufactuerers of America, Biotechnology Innovation Organization. Service: 09/12/2017 by email. [460406] [Thomas Saunders] [Entered: 09/12/2017 02:05 PM] (1) |
| Sep 12, 2017 | 61 | Entry of appearance for Christopher Asta as of counsel for Pharmaceutical Research and Manufacturers of America, Biotechnology Innovation Organization. Service: 09/12/2017 by email. [460409] [Christopher Asta] [Entered: 09/12/2017 02:13 PM] (1) |
| Sep 12, 2017 | 62 | TENDERED from Pharmaceutical Research and Manufacturers of America, Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service: 09/12/2017 by email. [460522] [Brian Boynton] [Entered: 09/12/2017 05:15 PM] (35) |
| Sep 12, 2017 | 63 | Notice of Correction to the Brief Doc No. [56], confidential Brief Doc No. [55] for Appellee Bristol-Myers Squibb Company. Service: 09/12/2017 by email. [460537] [Christopher Sipes] [Entered: 09/12/2017 06:04 PM] (3) |
| Sep 12, 2017 | 64 | TENDERED from Appellee Bristol-Myers Squibb Company. Title: CORRECTED RESPONSE BRIEF. Service: 09/12/2017 by email. [460538] [Christopher Sipes] [Entered: 09/12/2017 06:08 PM] (76) |
| Sep 12, 2017 | 65 | TENDERED from Appellee Bristol-Myers Squibb Company. Title: CORRECTED CONFIDENTIAL RESPONSE BRIEF Service: 09/12/2017 by email. [460539] [Christopher Sipes] [Entered: 09/12/2017 06:11 PM] (0) |
| Sep 12, 2017 | 66 | AMICUS BRIEF FILED for Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America [62]. Number of Pages: 26. Service: 09/12/2017 by email. The paper copies of the brief should be received by the court on or before 09/20/2017. Certificate of Interest is due on 09/27/2017. [460616] [CAB] [Entered: 09/13/2017 10:51 AM] (35) |
| Sep 12, 2017 | 67 | CORRECTED CONFIDENTIAL BRIEF FILED for Appellee Bristol-Myers Squibb Company [65]. Number of Pages: 59. Service: 09/12/2017 by email. The paper copies of the brief should be received by the court on or before 09/20/2017. [460646] [CAB] [Entered: 09/13/2017 12:02 PM] (0) |
| Sep 12, 2017 | 68 | CORRECTED BRIEF FILED for Appellee Bristol-Myers Squibb Company [64]. Number of Pages: 59. Service: 09/12/2017 by email. [460652] [CAB] [Entered: 09/13/2017 12:11 PM] (76) |
| Sep 5, 2017 | 55 | TENDERED from Appellee Bristol-Myers Squibb Company. Title: CONFIDENTIAL RESPONSE BRIEF Service: 09/05/2017 by email. [458760] This brief has been corrected. See Doc No. [67] [Christopher Sipes] [Entered: 09/05/2017 08:29 PM] (0) |
| Sep 5, 2017 | 56 | TENDERED from Appellee Bristol-Myers Squibb Company. Title: RESPONSE BRIEF. Service: 09/05/2017 by email. [458761] This brief has been corrected. See Doc No. [68] [Christopher Sipes] [Entered: 09/05/2017 08:31 PM] (0) |
| Sep 5, 2017 | 57 | CONFIDENTIAL BRIEF FILED for Appellee Bristol-Myers Squibb Company [55]. Number of Pages: 59. Service: 09/05/2017 by email. The paper copies of the brief should be received by the court on or before 09/15/2017. [459612] This brief has been corrected. See Doc No. [67] [CAB] [Entered: 09/08/2017 09:59 AM] (0) |
| Sep 5, 2017 | 58 | BRIEF FILED for Appellee Bristol-Myers Squibb Company [56]. Number of Pages: 59. Service: 09/05/2017 by email. Appellant's reply brief is due 09/19/2017. [459616] This brief has been corrected. See Doc No. [68] [CAB] [Entered: 09/08/2017 10:10 AM] (0) |
| Aug 9, 2017 | 54 | ORDER filed. The motion [52] is granted. BMS’s response brief is due no later than September 5, 2017, Momenta’s reply brief is due no later than September 19, 2017, and the joint appendix is due no later than September 21, 2017. The case shall be placed on the oral argument calendar after briefing is complete. Service: 08/09/2017 by clerk. [452620] [LMS] [Entered: 08/09/2017 12:11 PM] (2) |
| Aug 8, 2017 | 52 | MOTION of Appellee Bristol-Myers Squibb Company to extend the time to 09/05/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: opposed]. Service: 08/08/2017 by email. [452406] [Christopher Sipes] [Entered: 08/08/2017 04:58 PM] (7) |
| Aug 8, 2017 | 53 | RESPONSE of Appellant Momenta Pharmaceuticals, Inc. to the motion to extend time to file appellee/respondent/cross-appellant principal brief [52] filed by Appellee Bristol-Myers Squibb Company in 17-1694. Service: 08/08/2017 by email. [452447] [Deanne Maynard] [Entered: 08/08/2017 10:29 PM] (7) |
| Jul 13, 2017 | 51 | 6 paper copies of the Opening Brief [49] received from Appellant Momenta Pharmaceuticals, Inc. [446177] [CW] [Entered: 07/13/2017 11:14 AM] (0) |
| Jul 10, 2017 | 46 | TENDERED from Amicus Curiae Association for Accessible Medicines. Title: AMICUS CURIAE BRIEF. Service: 07/10/2017 by email. [445232] [William Schultz] [Entered: 07/10/2017 01:51 PM] (20) |
| Jul 10, 2017 | 47 | TENDERED from Appellant Momenta Pharmaceuticals, Inc.. Title: OPENING BRIEF. Service: 07/10/2017 by email. [445313] [Deanne Maynard] [Entered: 07/10/2017 03:33 PM] (130) |
| Jul 10, 2017 | 48 | 6 paper copies of the Amicus Brief [50] received from Amicus Curiae Association for Accessible Medicines. [445314] --[Edited 07/11/2017 by clerk to reference the proper document] [CW] [Entered: 07/10/2017 03:34 PM] (0) |
| Jul 10, 2017 | 49 | BRIEF FILED for Appellant Momenta Pharmaceuticals, Inc. [47]. Number of Pages: 64. Service: 07/10/2017 by email. The paper copies of the brief should be received by the court on or before 07/18/2017. Appellee's brief is due 08/21/2017. [445494] [CAB] [Entered: 07/11/2017 09:44 AM] (130) |
| Jul 10, 2017 | 50 | AMICUS BRIEF FILED for Association for Accessible Medicines [46]. Number of Pages: 13. Service: 07/10/2017 by email. Paper copies received 07/10/2017. [445558] [CAB] [Entered: 07/11/2017 11:34 AM] (20) |
| Jun 29, 2017 | 45 | ORDER filed. The motion [41] is granted to the extent that BMS’s response brief is due no later than August 21, 2017, Momenta’s reply brief is due no later than September 5, 2017, and the joint appendix is due no later than September 7, 2017. The case shall be placed on the oral argument calendar after briefing is complete. Any requests for extensions of time will be handled on a motion-by-motion basis. Service: 06/29/2017 by clerk. [443201] [LMS] [Entered: 06/29/2017 02:36 PM] (2) |
| Jun 28, 2017 | 44 | REPLY of Appellant Momenta Pharmaceuticals, Inc. to response , Doc. No [43]. Service: 06/28/2017 by email. [442940] [Deanne Maynard] [Entered: 06/28/2017 05:02 PM] (8) |
| Jun 27, 2017 | 43 | RESPONSE to the motion to expedite appeal [41] filed by Appellant Momenta Pharmaceuticals, Inc. in 17-1694. Service: 06/27/2017 by email. [442576] [Christopher Sipes] [Entered: 06/27/2017 05:40 PM] (10) |
| Jun 23, 2017 | 42 | ORDER filed. Any opposition to the motion to expedite appeal [41] shall be filed no later than June 27, 2017. Any reply in support of the motion is due no later than June 29, 2017.; Momenta’s opening brief is due no later than July 10, 2017. Service: 06/23/2017 by clerk. [441725] [NL] [Entered: 06/23/2017 02:18 PM] (2) |
| Jun 22, 2017 | 41 | MOTION of Appellant Momenta Pharmaceuticals, Inc. to expedite case. Any response is due within 10 days of service [Consent: opposed]. Service: 06/22/2017 by email. [441549] [Deanne Maynard] [Entered: 06/22/2017 06:01 PM] (12) |
| Jun 19, 2017 | 40 | ORDER filed. The motion to terminate appeal [11] is denied. Bristol-Myers Squibb is directed to address standing in its response brief.; The stay of proceedings is lifted.; Momenta's opening brief is due 08/18/2017. Service: 06/19/2017 by clerk. [440413] [NL] [Entered: 06/19/2017 02:46 PM] (2) |
| May 18, 2017 | 38 | REPLY of Appellee Bristol-Myers Squibb Company to response filed by Appellant in 17-1694 , Doc. No [25]. Service: 05/18/2017 by email. [432637] [Christopher Sipes] [Entered: 05/18/2017 04:11 PM] (35) |
| May 18, 2017 | 39 | Sealed or confidential document received [Appellee Bristol-Myers Squibb Company's Reply In Support of Motion to Dismiss For Lack of Jurisdiction] (corresponding to Doc No. [38]) for Appellee Bristol-Myers Squibb Company. Service: 05/18/2017 by email. [432638] [Christopher Sipes] [Entered: 05/18/2017 04:17 PM] (0) |
| May 15, 2017 | 37 | ORDER filed. The motion [24] is granted. Service: 05/15/2017 by clerk. [431559] [LMS] [Entered: 05/15/2017 04:22 PM] (2) |
| May 9, 2017 | 35 | Certificate of Interest for the Amicus Curiae Association for Accessible Medicines. Service: 05/09/2017 by email. [429882] [William Schultz] [Entered: 05/09/2017 10:39 AM] (2) |
| May 9, 2017 | 36 | 8 paper copies of the Amicus Brief [34] received from Amicus Curiae Association for Accessible Medicines. [430049] [KW] [Entered: 05/09/2017 03:06 PM] (0) |
| May 5, 2017 | 32 | Entry of appearance for Carlos T. Angulo as of counsel for Association for Accessible Medicines. Service: 05/05/2017 by email. [429416] [Carlos Angulo] [Entered: 05/05/2017 02:32 PM] (4) |
| May 5, 2017 | 33 | Entry of appearance for Jeremy S. Kreisberg as of counsel for Association for Accessible Medicines. Service: 05/05/2017 by email. [429420] [William Schultz] [Entered: 05/05/2017 02:41 PM] (4) |
| May 5, 2017 | 34 | This entry was made in error and has been removed from the docket. AMICUS BRIEF FILED for Association for Accessible Medicines [30]. Number of Pages: 12. Service: 05/04/2017 by email. The paper copies of the brief should be received by the court on or before 05/12/2017. Certificate of Interest is due on 05/19/2017. [429440] --[Edited 07/11/2017 by clerk. Document is a response to Appellee's motion to terminate appeal. See Doc No. [30]. [CAB] [Entered: 05/05/2017 03:05 PM] (0) |
| May 4, 2017 | 28 | Entry of appearance for William B. Schultz as principal counsel for Association for Accessible Medicines. Service: 05/04/2017 by email. [429103] [William Schultz] [Entered: 05/04/2017 11:26 AM] (4) |
| May 4, 2017 | 29 | MOTION of Association for Accessible Medicines for leave to file an amicus curiae brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 05/04/2017 by email. [429220] [William Schultz] [Entered: 05/04/2017 02:32 PM] (6) |
| May 4, 2017 | 30 | CORRECTED ENTRY: RESPONSE of Amicus Curiae Association for Accessible Medicines to the motion to terminate appeal [11] filed by Appellee Bristol-Myers Squibb Company in 17-1694. Service: 05/04/2017 by email. [429226] --[Edited 07/11/2017 by clerk to correct event selected] [William Schultz] [Entered: 05/04/2017 02:36 PM] (19) |
| May 4, 2017 | 31 | ORDER granting motion for leave to file an amicus curiae brief [29]. The brief is accepted for filing. Service: 05/04/2017 by clerk. [429275] [NL] [Entered: 05/04/2017 05:21 PM] (2) |
| May 1, 2017 | 27 | ORDER filed. The motion [22] is granted. Bristol-Myers Squibb Company's reply to Momenta Pharmaceuticals, Inc.'s response to the motion to terminate this appeal is due on or before May 18, 2017. Service: 05/01/2017 by clerk. [428151] [LMS] [Entered: 05/01/2017 11:24 AM] (2) |
| Apr 27, 2017 | 18 | Entry of appearance for Joseph R. Palmore as of counsel for Appellant Momenta Pharmaceuticals, Inc.. Service: 04/27/2017 by email. [427668] [Joseph Palmore] [Entered: 04/27/2017 04:58 PM] (2) |
| Apr 27, 2017 | 19 | Entry of appearance for Brian M. Kramer as of counsel for Appellant Momenta Pharmaceuticals, Inc.. Service: 04/27/2017 by email. [427670] [Brian Kramer] [Entered: 04/27/2017 05:01 PM] (2) |
| Apr 27, 2017 | 20 | Entry of appearance for Bradley K. Ervin as of counsel for Appellee Bristol-Myers Squibb Company. Service: 04/27/2017 by email. [427672] [Bradley Ervin] [Entered: 04/27/2017 05:25 PM] (2) |
| Apr 27, 2017 | 21 | Amended Certificate of Interest for the Appellee Bristol-Myers Squibb Company. Service: 04/27/2017 by email. [427685] [Christopher Sipes] [Entered: 04/27/2017 06:00 PM] (3) |
| Apr 27, 2017 | 22 | MOTION of Appellee Bristol-Myers Squibb Company to extend time until 05/18/2017 at 11:59 pm to file (a reply brief in support of Appellee's motion to dismiss appeal). [Consent: unopposed]. Service: 04/27/2017 by email. [427687] [Christopher Sipes] [Entered: 04/27/2017 06:08 PM] (6) |
| Apr 27, 2017 | 23 | Amended Certificate of Interest for the Appellant Momenta Pharmaceuticals, Inc.. Service: 04/27/2017 by email. [427690] [Deanne Maynard] [Entered: 04/27/2017 07:15 PM] (3) |
| Apr 27, 2017 | 24 | MOTION of Appellant Momenta Pharmaceuticals, Inc. for entry of protective order. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/27/2017 by email. [427691] [Deanne Maynard] [Entered: 04/27/2017 07:18 PM] (14) |
| Apr 27, 2017 | 25 | RESPONSE of Appellant Momenta Pharmaceuticals, Inc. to the motion to terminate appeal [11] filed by Appellee Bristol-Myers Squibb Company in 17-1694. Service: 04/27/2017 by email. [427692] [Deanne Maynard] [Entered: 04/27/2017 07:19 PM] (338) |
| Apr 27, 2017 | 26 | Sealed or confidential document received [Confidential Appellant's Opposition to Motion to Dismiss for Lack of Jurisdiction] (corresponding to Doc No. [25]) for Appellant Momenta Pharmaceuticals, Inc.. Service: 04/27/2017 by email. [427693] [Deanne Maynard] [Entered: 04/27/2017 07:21 PM] (0) |
| Apr 18, 2017 | 17 | ORDER filed. The motion [16] is granted. Momenta Pharmaceuticals, Inc.'s response to Bristol-Myers Squibb Company's motion to terminate the appeal is due on or before April 27, 2017. Service: 04/18/2017 by clerk. [425251] [LMS] [Entered: 04/18/2017 04:04 PM] (2) |
| Apr 13, 2017 | 16 | MOTION of Appellant Momenta Pharmaceuticals, Inc. to extend the time to 04/27/2017 at 11:59 pm file a response/reply to the motion to terminate appeal [11]. [Consent: unopposed]. Service: 04/13/2017 by email. [424039] [Deanne Maynard] [Entered: 04/13/2017 06:44 PM] (5) |
| Apr 10, 2017 | 15 | Certified list from the United States Patent and Trademark Office. Service: 04/10/2017 by email. [422759] [CMP] [Entered: 04/10/2017 01:34 PM] (25) |
| Mar 31, 2017 | 14 | ORDER filed. The motion [12] is granted. Momenta's response to the motion to terminate is due no later than April 20, 2017. Service: 03/31/2017 by clerk. [420619] [LMS] [Entered: 03/31/2017 11:28 AM] (2) |
| Mar 29, 2017 | 12 | MOTION of Appellant Momenta Pharmaceuticals, Inc. to extend the time to 04/20/2017 at 11:59 pm file a response/reply to the motion to terminate appeal [11]. [Consent: unopposed]. Service: 03/29/2017 by email. [420021] [Deanne Maynard] [Entered: 03/29/2017 03:04 PM] (6) |
| Mar 29, 2017 | 13 | Entry of appearance for Seth W. Lloyd as of counsel for Appellant Momenta Pharmaceuticals, Inc.. Service: 03/29/2017 by email. [420029] [Seth Lloyd] [Entered: 03/29/2017 03:11 PM] (2) |
| Mar 27, 2017 | 11 | MOTION of Appellee Bristol-Myers Squibb Company to terminate appeal through Dismissal. [Consent: opposed]. Service: 03/27/2017 by email. [419183] [Christopher Sipes] [Entered: 03/27/2017 03:12 PM] (301) |
| Mar 14, 2017 | 2 | Entry of appearance for Deanne E. Maynard as principal counsel for Appellant Momenta Pharmaceuticals, Inc.. Service: 03/14/2017 by email. [415259] [Deanne Maynard] [Entered: 03/14/2017 12:11 PM] (2) |
| Mar 14, 2017 | 3 | Certificate of Interest for the Appellant Momenta Pharmaceuticals, Inc.. Service: 03/14/2017 by email. [415260] [Deanne Maynard] [Entered: 03/14/2017 12:11 PM] (2) |
| Mar 14, 2017 | 4 | Docketing Statement for the Appellant Momenta Pharmaceuticals, Inc.. Service: 03/14/2017 by email. [415261] [Deanne Maynard] [Entered: 03/14/2017 12:12 PM] (4) |
| Mar 14, 2017 | 5 | Entry of appearance for Brian R. Matsui as of counsel for Appellant Momenta Pharmaceuticals, Inc.. Service: 03/14/2017 by email. [415262] [Brian Matsui] [Entered: 03/14/2017 12:13 PM] (2) |
| Mar 14, 2017 | 6 | Entry of appearance for Christopher N. Sipes as principal counsel for Appellee Bristol-Myers Squibb Company. Service: 03/14/2017 by email. [415315] [Christopher Sipes] [Entered: 03/14/2017 01:53 PM] (2) |
| Mar 14, 2017 | 7 | Entry of appearance for George F. Pappas as of counsel for Appellee Bristol-Myers Squibb Company. Service: 03/14/2017 by email. [415333] [George Pappas] [Entered: 03/14/2017 02:08 PM] (2) |
| Mar 14, 2017 | 8 | Entry of appearance for Megan P. Keane as of counsel for Appellee Bristol-Myers Squibb Company. Service: 03/14/2017 by email. [415339] [Megan Keane] [Entered: 03/14/2017 02:12 PM] (2) |
| Mar 14, 2017 | 9 | Certificate of Interest for the Appellee Bristol-Myers Squibb Company. Service: 03/14/2017 by email. [415344] [Christopher Sipes] [Entered: 03/14/2017 02:16 PM] (2) |
| Mar 14, 2017 | 10 | Docketing Statement for the Appellee Bristol-Myers Squibb Company. Service: 03/14/2017 by email. [415345] [Christopher Sipes] [Entered: 03/14/2017 02:17 PM] (3) |
| Feb 28, 2017 | 1 | Appeal docketed. Received: 02/22/2017. [411110] Entry of Appearance due 03/14/2017. Certificate of Interest is due on 03/14/2017. Docketing Statement due 03/14/2017. Certified List due on 04/10/2017. [CAB] [Entered: 02/28/2017 10:44 AM] (24) |
